Currentblue cross blue shield - south dakotaPolicy N/A

Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)

This medical policy governs the use and coverage determination for laser discectomy and radiofrequency coblation (disc nucleoplasty) for individuals with discogenic low back pain or radiculopathy under Wellmark (Blue Cross Blue Shield - South Dakota) plans.

Policy Summary

Payerblue cross blue shield - south dakota

PolicyDecompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateOriginal Effective Date: October 2010

Next Review DateAugust 2025

Key ActionVerify member benefits and document prior conservative therapy and imaging-confirmed target lesion before considering these investigational procedures.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

MultipleRCTs for nucleoplasty

1RCTs for laser discectomy

510(k)Device pathway

31% vs 19%Median re-op rate (laser vs open)

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Observed progressive degeneration after nucleoplasty

Coverage Determination and Evidence Summary

Investigational / Not supported

Covered status and evidence summary

Policy stance: Laser discectomy and radiofrequency coblation (disc nucleoplasty) are considered investigational as techniques of disc decompression and treatment of associated pain.

Policy conclusion based on insufficient evidence to determine improvement in net health outcome.

Evidence limitations

Evidence limitations cited

Evidence concerns for laser discectomy: RCTs and observational studies exist but are limited by small numbers, uncontrolled designs, and inability to draw firm conclusions about net health benefit; observational studies alone are insufficient given the variable natural history and potential placebo effects.

The single RCT (n=82) found no difference versus open surgery; numerous case series comprise most evidence.

Evidence concerns for nucleoplasty: Although several RCTs exist, they are limited by lack of blinding, inadequate control conditions, incomplete reporting, low enrollment, and early termination in some trials; these methodological issues and confounding limit confidence in effect estimates.

High-quality randomized trials with adequate follow-up (≥1 year) are needed.

Laser discectomy — evidence summary

Evidence summary and contexts in which procedures were studied

Laser Discectomy Evidence Summary: Evidence includes 1 randomized controlled trial (Seddighi et al) and multiple observational studies. The RCT randomized approximately 84 patients to percutaneous laser disc decompression versus open surgery with 2-year follow-up and found no statistically significant differences in pain and disability; median reoperation rates were 31% for laser and 19% for open surgery (difference not statistically significant). Most other data are from case series and uncontrolled studies, limiting interpretation.

Follow-up in trials was 2 years; observational evidence is subject to confounding and the variable natural history of back pain.

Disc nucleoplasty — evidence summary

Disc nucleoplasty (radiofrequency coblation) evidence summary

Disc Nucleoplasty Evidence Summary: The evidence base includes multiple randomized controlled trials (e.g., Gerszten et al 2010, Chitragran 2012, de Rooij 2020) and nonrandomized studies. Gerszten (lumbar) showed greater short-term (6 month) improvements in pain and function compared with two epidural steroid injections, with mixed secondary-procedure rates at 1 year. de Rooij (cervical) found early benefit for anterior cervical discectomy at 3 months and the trial was underpowered due to low enrollment. Overall, RCTs have limitations (unblinded designs, inadequate controls, incomplete data reporting, low enrollment), and results are insufficient to conclude a net health benefit.

Trials often enrolled patients after failed conservative care or prior epidural steroid injection; ideal follow-up is ≥1 year to assess durability and secondary-procedure rates.

Laser discectomy and radiofrequency coblation (disc nucleoplasty) are considered investigational as techniques for disc decompression and treatment of associated pain. The policy concludes that the available evidence is insufficient to determine an improvement in net health outcome, and services would therefore not meet coverage under this policy stance.

Clinical trial reports and comparative observational studies frequently excluded patients with sequestered discs and generally required some preservation of disc height or contained herniation for enrollment. Several large series and retrospective comparisons explicitly excluded sequestered/extruded fragments, reflecting trial eligibility that limits generalizability to those populations.

Observational data have signaled potential harms and reduced effectiveness in some settings: one series reported progressive degeneration at the treated level in 32% of patients after nucleoplasty within one year, and nonrandomized cohort data found nucleoplasty performed worse than microdiscectomy for disc extrusion with higher rates of unsatisfactory results and subsequent microdiscectomy. These findings limit use of nucleoplasty for extruded discs and raise concerns about accelerated degeneration that require further study with adequate imaging follow-up.

The rationale for the investigational designation is that randomized trials and observational studies are limited by small sample sizes, uncontrolled designs, lack of blinding, incomplete reporting, and short or inadequate follow-up. Because of these methodological limitations and the variable natural history of low back pain, the evidence is insufficient to demonstrate an improvement in net health outcome for laser discectomy or nucleoplasty.

Evidence on percutaneous laser disc decompression (laser discectomy) is dominated by observational series and a single RCT (n=82) that found no difference versus open surgery in pain and disability at 2 years and reported a higher median reoperation rate (31% vs 19%) for laser that did not reach statistical significance. Observational studies lack controls and cannot exclude placebo effects or selection bias, so they are insufficient to establish effectiveness of laser discectomy.

Nonrandomized cohort data comparing nucleoplasty with microdiscectomy showed worse outcomes for nucleoplasty in patients with disc extrusion, including higher rates of unsatisfactory results and subsequent microdiscectomy. Additionally, case series and an observational study have reported concerns about accelerated disc degeneration after nucleoplasty, underscoring limitations of the existing nonrandomized evidence.

Procedure and Billing Codes

CPT codesCPT

62287

Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, any method utilizing needle-based technique to remove disc material under fluoroscopic imaging or other form of indirect visualization, with discography and/or epidural injection(s) at the treated level(s), when performed, single or multiple levels, lumbar.

HCPCS codesHCPCS

S2348

Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar.

Provider Requirements, Prior Authorization, and Billing Guidance

Note

Prior Approval

Prior approval not applicable. Verify member benefits and contract terms prior to scheduling services.

Prior Authorization

Prior Authorization / Documentation Expectations

Prior authorization may be required by the member's benefit plan. When prior authorization is requested, verify and document prior conservative care (e.g., physical therapy, medication management) and imaging-confirmed target lesion (MRI or equivalent) as often required in clinical trials and coverage determinations.

Document prior conservative therapy attempts and duration (e.g., ≥12 weeks where applicable).
Provide imaging confirmation of contained herniation or target lesion (MRI preferred).

Clinical Background

Discogenic low back pain is a multifactorial syndrome characterized by low back pain without radicular findings and with radiologically confirmed degenerative disc disease. Minimally invasive percutaneous decompression techniques described in the literature include laser discectomy—insertion of a needle or catheter to vaporize nucleus tissue with laser energy—and radiofrequency coblation (disc nucleoplasty), which uses bipolar radiofrequency energy to ablate nucleus pulposus tissue in a controlled plasma field. These procedures have been studied as alternatives to continued conservative care or conventional discectomy, but current evidence does not establish consistent net clinical benefit.

Terms and Procedure Definitions

Discogenic Low Back Pain — definition and distinguishing features

DefinitionLow back pain without radicular symptom findings, with radiologically confirmed degenerative disc disease.

Clinical featuresMultifactorial syndrome presenting with axial low back pain in the absence of radicular neurologic findings.

Imaging requirementRadiologic confirmation of degenerative disc disease (e.g., MRI) is part of the definition and is used to identify candidate lesions.

Laser discectomy — definition of percutaneous laser procedure

DefinitionA percutaneous procedure in which a needle or catheter is inserted into the disc nucleus and a laser beam is directed through it to vaporize tissue to decompress the intervertebral disc.

Technique details

Policy Summary

Payerblue cross blue shield - south dakota

PolicyDecompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateOriginal Effective Date: October 2010

Next Review DateAugust 2025

Key ActionVerify member benefits and document prior conservative therapy and imaging-confirmed target lesion before considering these investigational procedures.

SourceLink

On This Page

Step Therapy

Conservative Therapy and Step Therapy Expectations

Conservative therapy (physical therapy, medications, and other noninvasive management) should precede consideration of percutaneous disc decompression procedures. Step therapy expectations include using conservative management and epidural steroid injection as comparators before intervention in many study protocols and payer practices.

Document trials of conservative care and any epidural steroid injections and response to those therapies.
Trials frequently required prior conservative care and, for some trials, failure of epidural steroid injection prior to enrollment.

Denial Risk

Investigational — Potential for Denial

Disc nucleoplasty and related percutaneous decompression techniques are considered investigational by this policy. In the absence of sufficient high-quality comparative evidence demonstrating net health benefit, requests may be denied as investigational and not covered under the plan.

Evidence limitations (lack of high-quality comparative data) may trigger denial decisions.
One RCT compared nucleoplasty with epidural steroid injections and had high crossover in the control arm, complicating interpretation of benefit.

Billing Rule

Billing, Coding, and Claims Submission Guidance

Claims for percutaneous decompression procedures should be reported using appropriate CPT, HCPCS, Revenue, and ICD-10 diagnosis codes. Include supporting documentation of medical necessity (indication, prior conservative management, imaging confirming target lesion) with the claim or prior authorization submission.

Use CPT 62287 when reporting percutaneous decompression of nucleus pulposus (needle-based technique) as appropriate.
Use HCPCS S2348 for percutaneous decompression procedure using radiofrequency energy, lumbar, single or multiple levels.
Include relevant revenue and ICD-10 diagnosis codes that reflect discogenic pain or confirmed herniation.
Ensure documentation of prior conservative care, imaging results, and targeted level(s) is available for review.

Performed under fluoroscopic guidance; various lasers have been used (YAG, KTP, holmium, argon, CO2) with differing energy absorption and activation protocols.

Intended effectRemoval/vaporization of nucleus material to reduce disc pressure and relieve discogenic or radicular pain.

Disc nucleoplasty (radiofrequency coblation) — definition describing plasma field ablation

DefinitionA percutaneous procedure using bipolar radiofrequency energy in an electrically conductive fluid to generate a plasma field that ablates nucleus pulposus tissue to decompress the disc.

MechanismCoblation creates a low-temperature, high-density plasma field of ionizing particles that break organic bonds within target tissue, allowing controlled localized ablation.

Procedure setupProcedure is accomplished with a probe connected to a radiofrequency coblation source, typically performed under imaging guidance.

Disc nucleoplasty — alternative definition / description of radiofrequency coblation technique

Alternative descriptionRadiofrequency coblation (nucleoplasty) uses bipolar low-frequency energy in a conductive fluid (e.g., saline) to generate a plasma field that produces controlled ablation of disc tissue to reduce disc bulge and relieve radicular or discogenic pain.

Clinical rationaleProposed advantage is highly localized ablation with minimal damage to surrounding tissues compared with other thermal techniques.

Common useInvestigated as a minimally invasive alternative to conservative therapy or conventional discectomy for contained disc lesions.

Percutaneous laser disc decompression — definition for laser energy decompression

DefinitionPercutaneous laser disc decompression (laser discectomy) is a minimally invasive, image-guided procedure using laser energy delivered into the disc nucleus to vaporize disc material and decompress the intervertebral disc.

Clinical study contextStudied in randomized trials (e.g., Seddighi et al) comparing percutaneous laser disc decompression with open surgery for radicular pain from lumbar disc herniation.

Technical variabilityDifferent laser types and variable treatment protocols (duration/intensity) have been used; exact amount of tissue removal needed for decompression is uncertain.

Nucleoplasty / percutaneous disc decompression — general definition when using radiofrequency techniques

DefinitionNucleoplasty or percutaneous disc decompression is a needle-based, fluoroscopically guided procedure to remove or ablate nucleus pulposus material; when radiofrequency techniques are used this involves coblation to ablate tissue and decompress the disc.

Coding noteCPT 62287 and HCPCS S2348 are the codes referenced for reporting percutaneous decompression procedures using needle-based techniques and radiofrequency energy, respectively.

PurposeIntended to reduce disc bulge and relieve symptoms related to discogenic back pain or radiculopathy as an alternative to conservative therapy or open surgery.